← Open Payments lookup

ROUEEN RAFEYAN: Open Payments

NPI 1003891458 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$401,887 in 385 payments from 14 companies in 2025. Trend: 2023 $429,504 · 2024 $369,086 · 2025 $401,887

Speaker / faculty: $313,127Travel & lodging: $32,924Consulting: $29,290Honoraria: $15,525Food & beverage: $11,021
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)82$84,097
Neurocrine BioSciences, Inc.59$78,796
E.R. Squibb & Sons, L.L.C.56$54,108
Alkermes, Inc.56$53,148
Teva Pharmaceuticals USA, Inc.35$52,781
Otsuka America Pharmaceutical, Inc.39$44,642
Axsome Therapeutics, Inc.21$16,944
Vanda Pharmaceuticals Inc.15$9,966
ABBVIE INC.7$6,524
Janssen Pharmaceuticals, Inc6$711

Products named: CAPLYTA, INGREZZA, COBENFY, REXULTI, LYBALVI, UZEDY, AUSTEDO XR, ARISTADA.

Industry payments across IL — which companies pay providers there.